News

Zacks Investment Research on MSN23h
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag
Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...
Sanofi Geographic Atrophy Treatment Gets FDA's Fast Track Designation
Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...